⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Agilent Technologies made minimal structural changes to its risk factor disclosures between 2022 and 2023, maintaining 30 unchanged risks while modifying only 3 existing disclosures. The three substantive modifications addressed debt management and financial obligations, evolving corporate governance and regulatory compliance requirements, and the ongoing impact of public health crises on business operations. These changes reflect refinements to existing risk narratives rather than a shift in Agilent's overall risk profile or strategic focus.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟡 Modified We have outstanding debt and may incur other debt in the future, which could adversely affect our financial condition, liquidity and results of operations. 🔒

🟡 Modified We are subject to evolving corporate governance and public disclosure expectations and regulations that impact compliance costs and risks of noncompliance. 🔒

🟡 Modified Public health crises such as the COVID-19 pandemic may adversely impact, and pose risks to, certain elements of our business, results of operations and financial condition, the nature and extent of which are highly uncertain and unpredictable. 🔒

3 changes in this historical filing

Historical year-over-year comparisons (2023 vs 2022 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →